Effects of vitamin D3 on keratinocyte proliferation and differentiation in vitro: Modulation by ligands for retinoic acid and retinoid X receptors

Skin Pharmacology and Physiology

Volumn 10, Issue 3, 1997, Pages 144-152

  Sorensen S ^a   Solvsten H ^a   Politi, Y ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b Ichilow Municipal Hospital   (Israel)

Author keywords

9 Cis retinoic acid; All trans retinoic acid; Differentiation; Keratinocytes; Proliferation; Vitamin D3

Indexed keywords

ALITRETINOIN; CALCITRIOL; LIGAND; LIOTHYRONINE; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; THYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR; CELL RECEPTOR; COLECALCIFEROL; LIOTHYRONINE RECEPTOR; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; VITAMIN D RECEPTOR;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; CYTOLOGY; DRUG EFFECT; DRUG INTERACTION; HUMAN; KERATINOCYTE; METABOLISM; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; RECEPTOR AFFINITY;

CALCITRIOL; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; DRUG INTERACTIONS; HUMANS; KERATINOCYTES; LIGANDS; RECEPTORS, RETINOIC ACID; RECEPTORS, THYROID HORMONE; RETINOID X RECEPTORS; TRANSCRIPTION FACTORS; TRETINOIN; TRIIODOTHYRONINE;

EID: 0030823259     PISSN: 16605527     EISSN: 16605535     Source Type: Journal    
DOI: 10.1159/000211479     Document Type: Article

References (33)

1. 5 results in differentiation towards neutrophils or a failure to differentiate and apoptosis, Leukemia 1995:9:410-418.
2. 3 and malignant melanoma: The presence of receptors and inhibition of cell growth in culture, Endocrinology 1981;108:1083-1086.
3. Frampton RJ, Omond SA, Eisman JA: Inhibition of human cancer growth by 1.25-dihydroxyvitamin D3 metabolites, Cancer Res 1983: 43:4443-4447.
4. (and rctinoic acid (all trans or 9-cis), J Steroid Biochem Mol Biol 1995: 53:431-441.
5. Hosomi J, Hosomi J, Abe E, Suda T, Kuroki T: Regulation of terminal differentiation of cultured mouse epidermal cells by lu,25-dihydroxy-vitamin Dj, Endocrinology 1983:3: 1950-1957.
6. 3 analogue stimulates terminal differentiation and inhibits proliferation of cultured human kératinocytes, Arch Dermatol Res 1990:282:164-167.
7. 3 011 normal human kératinocytes cultured in serum-free medium, Biochem Bio-phys Res Commun 1990; 166:916-923.
8. 3 on the morphologic and biochemical differentiation of cultured human epidermal kératinocytes grown in serum-free conditions, J Invest Dermatol 1986:86:709-714.
9. Mangelsdorf DJ, Ong ES, Dyck JA, Evans RM: Nuclear receptor that identifies a novel rctinoic acid response pathway, Nature 1990:345: 224-229.
10. Mangelsdorf DJ, Borgmeyer U, Heyman RA, Zhou JY, Ong ES, Oro AE, Kakizuka A, Evans RM: Characterization of three RXR genes that mediate the action of 9-cis retinoic aicd, Genes Dev 1992;6:329-344.
11. Fisher GJ, Talwar HS, Xiao JH, Datta SC, Reddy AP, Gaub MP, Ro-chette-Egly C, Chambon P, Voor-hees JJ: Immunological identification and functional quantitation of retinoic acid and retinoid X receptor proteins in human skin, J Biol C'hem 1994;269:20629-20635.
12. Rcichrath J, Miinssinger T, Kerber A, Rochette-Egly C, Chambon P, Bahmcr FA, Baum HP: In situ detection of retinoid X-receptor expression in normal and psoriatic human skin, Br J Dermatol 1995:133: 168-175.
13. Elder JT, Fisher GJ, Zhang QY, Eisen D, Krust A, Kästner P, Cham-bon P, Voorhees JJ: Reiinoic acid receplor gene expression in human skin, J Invest Dermatol 1991:96: 425-433.
14. Törma II, Rollman O, Vahlquist A: Detection of mRNA transcripts for retinois acid, vitamin D, i, and thyroid hormone (oerb-A) nuclear receptors in human skin using reverse transcription and polymerase chain reaction, Acta Derm Vencreol 1993: 73:102-107.
15. Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM, Thaller C: 9-Cis retinoic acid is a high affinity ligand for the retinoid X receptor, Cell 1992;68:397-406.
16. Levin AA, Sturzenbecker LJ, Kammer S, Bosakowski T, Husclton C, Allenby G, Speck J, Kratzeisen C, Rosenberger M, Lovcy A, Grippo JF: 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRu, Nature 1992:355: 359-361.
17. Allenby G, Bocquel MT, Saunders M, Kazmer S, Speck J, Rosenberger M, Lovey A, Kastner P, Grippo JF, Chambon P, Levin AL: Retinoic acid receptors and retinoid X receptors: Interactions with endogenous retinoic acids, Proc Natl Acad Sei USA 1993;90:30-34.
18. Bugge T, Pohl J, Lonnoy O, Stun-nenberg HG: RXRa, a promiscuous partner of retinoic acid and thyroid hormone receptors, EMBO J 1992: 11:1409-1418.
19. Kliewer SA, Umesono K, Mangelsdorf DJ, Evans RM: Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin Dj signalling, Nature 1992;355:446-449.
20. Zhang X, Hoffmann B, Tran PBV, Graupner G, Pfahl M: Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors, Nature 1992:355:441-446.
21. Nakajima S, Hsich JC, MacDonald PN, Galligan MA, Haussler CA, Whitfield GK, Haussler MR: The C-terminal region of the vitamin D receptors is essential to form a complex with a receptor auxiliary factor required for high affinity binding to the vitamin D-responsive element, Mol Endocrinol 1994:8:159-172.
22. Umcsono K, Murakami KK, Thompson CC, Evans RM: Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin Dj receptors, Cell 1991:65:1255-1266.
23. 3 analogues in a cell density-, calcium- and serum-dependent manner, Pharmacol Toxicol (in press).
24. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays, J Immunol Methods 1983:65:55-63.
25. Michel S, Courscaux A, Miquel C, Bemardon JM, Schmidt R, Shroot B, Thacher SM, Reichert U: Determination of retinoid activity by an enzyme-linked immunosorbent assay, Anal Biochem 1991:192:232-236.
26. Henriksen LO, Kragballe K, Jensen TG, Fogli K: Transcriptional activation by 1.25-dihydroxyvitamin D-, and synthetic vitamin Di analogues in transfected cultures of human keratinocytes, Skin Pharmacol 1997;10:12-20.
27. Carlberg C, Bendik I, Wyss A: Two nuclear signaling pathways for vitamin D, Nature 1993:361:657-660.
28. Gniadecki R: Stimulation versus inhibition of kératinocyte growth by 1.25-dihydroxyvitamin Dj: Dependence on cell culture conditions, J Invest Dermatol 1996; 106:510-516.
29. 3 arc potentiated by epidermal growth factor and attenuated by insulin in cultured human keratinocytes, J Invest Dermatol 1995:104(1):113-117.
30. Defacque H, Domand J, Commes T, Cabane C, Sevilla C, Marti J: Different combinations of retinoids and vitamin D3 analogs efficiently promote growth inhibition and differentiation of myclomonocytic leukemia cell lines, J Pharmacol Ther 1994;271:193-199.
31. Reynolds NJ, Fisher GJ, Griffiths CEM, Tavakkol A, Talwar HS, Rowsc PE, Hamilton TA, Voorjecs JJ: Retinoic acid metabolites exhibit biological activity in human keratinocytes, mouse melanoma cells and hairless mouse skin in vivo, J Pharmacol Ther 1993:266:1636-1642.
32. Michel S, Reichert U, Isnard JL, Shroot B, Schmidt R: Retinoic acid controls expression of epidermal transglutaminase at the prc-transla-tional level, FEBS Lett 1989:258(1): 35-38.
33. Liew FM, Yamanishi K: Regulation of transglutaminase I gene expression by 12-O-tetradecanoylphorbol-13-acetate, dcxamethasone, and rct-inoic acid in cultured human kerati-nocvtes, Exp Cell Res 1992:202: 310-315.